These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30497810)

  • 1. Testicular Cancer Biomarkers: A Role for Precision Medicine in Testicular Cancer.
    Leão R; Ahmad AE; Hamilton RJ
    Clin Genitourin Cancer; 2019 Feb; 17(1):e176-e183. PubMed ID: 30497810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNAs orchestration of testicular germ cell tumors - Particular emphasis on diagnosis, progression and drug resistance.
    Elesawy AE; Abulsoud AI; Moustafa HAM; Elballal MS; Sallam AM; Elazazy O; El-Dakroury WA; Abdel Mageed SS; Abdelmaksoud NM; Midan HM; Shahin RK; Elrebehy MA; Nassar YA; Elazab IM; Elballal AS; Elballal MS; Doghish AS
    Pathol Res Pract; 2023 Aug; 248():154612. PubMed ID: 37327566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNAs for testicular germ cell tumours: Contemporary indications for diagnosis, surveillance and follow-up.
    Chavarriaga J; Hamilton RJ
    Andrology; 2023 May; 11(4):628-633. PubMed ID: 36373757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum tumour markers in germ cell tumours: From diagnosis to cure.
    Pedrazzoli P; Rosti G; Soresini E; Ciani S; Secondino S
    Crit Rev Oncol Hematol; 2021 Mar; 159():103224. PubMed ID: 33493632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
    Bezan A; Gerger A; Pichler M
    Anticancer Res; 2014 Jun; 34(6):2709-13. PubMed ID: 24922631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
    Terbuch A; Adiprasito JB; Stiegelbauer V; Seles M; Klec C; Pichler GP; Resel M; Posch F; Lembeck AL; Stöger H; Szkandera J; Pummer K; Bauernhofer T; Hutterer GC; Gerger A; Stotz M; Pichler M
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testicular cancer.
    Hellerstedt BA; Pienta KJ
    Curr Opin Oncol; 2002 May; 14(3):260-4. PubMed ID: 11981269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New prognostic markers and potential therapeutic targets in human testicular germ cell tumors.
    Chieffi P
    Curr Med Chem; 2011; 18(33):5033-40. PubMed ID: 22050751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testicular Germ Cell Tumors: Serological and Immunohistochemical Diagnosis.
    Damjanov I
    Acta Med Acad; 2021 Apr; 50(1):58-70. PubMed ID: 34075764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in molecular and cell biology of testicular germ-cell tumors.
    Chieffi P
    Int Rev Cell Mol Biol; 2014; 312():79-100. PubMed ID: 25262239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [EAU guidelines on testicular cancer: 2011 update. European Association of Urology].
    Albers P; Albrecht W; Algaba F; Bokemeyer C; Cohn-Cedermark G; Fizazi K; Horwich A; Laguna MP;
    Actas Urol Esp; 2012 Mar; 36(3):127-45. PubMed ID: 22188753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Clinical Applications of Testicular Cancer Biomarkers.
    Mir MC; Pavan N; Gonzalgo ML
    Urol Clin North Am; 2016 Feb; 43(1):119-25. PubMed ID: 26614034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Prognostic Biomarkers in Testicular Germ Cell Tumors: Looking Beyond Established Practice.
    Chovanec M; Albany C; Mego M; Montironi R; Cimadamore A; Cheng L
    Front Oncol; 2018; 8():571. PubMed ID: 30547014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Overview on Predictive Biomarkers of Testicular Germ Cell Tumors.
    Chieffi P
    J Cell Physiol; 2017 Feb; 232(2):276-280. PubMed ID: 27405110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doctor's dilemma: incorporating tumor markers into clinical decision-making.
    Canil CM; Tannock IF
    Semin Oncol; 2002 Jun; 29(3):286-93. PubMed ID: 12063682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors.
    Chovanec M; Cierna Z; Miskovska V; Machalekova K; Svetlovska D; Kalavska K; Rejlekova K; Spanik S; Kajo K; Babal P; Mardiak J; Mego M
    Oncotarget; 2017 Mar; 8(13):21794-21805. PubMed ID: 28423520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The search for biomarkers of metastatic seminoma.
    Ruf CG; Khalili-Harbi N; Sachs S; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
    J Urol; 2013 Sep; 190(3):1046-51. PubMed ID: 23583226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Εmerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors.
    Evmorfopoulos K; Vlachostergios PJ; Sountoulides P; Tzortzis V
    Curr Cancer Drug Targets; 2023; 23(11):858-867. PubMed ID: 36967458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
    Kawai T; Tanaka Y;
    Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer.
    Syring I; Bartels J; Holdenrieder S; Kristiansen G; Müller SC; Ellinger J
    J Urol; 2015 Jan; 193(1):331-7. PubMed ID: 25046619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.